Although Alzheimer's Disease (AD) is characterized classically by dementia associated with a variety of neuropathologic features, it is likely that there is no single pathologic change that alone is the basis for the cognitive and behavioral impairment. In this proposal, we hypothesize that the pathogenetic mechanism for dementia involves quantitative and variable neuronal cell body and synaptic losses occurring concurrently in multiple brain structures to reach a threshold of loss that results in dementia, especially when combined with the aging process. To substantiate multifactorial origins of dementia, we will identify losses that occur in the brains of patients diagnosed as having dementia due to AD by comparing them with the brains of cognitively normal aged subjects. Consecutive series of tissue sections will be prepared form neuronal regions known to be involved in cognitive and behavioral function, including the hippocampal complex, amygdala, portions of the frontal and temporal lobes, and the nucleus basalis of Meynert. As a marker of synaptic terminals, we will validate and extend the use of antibodies to synapsin. Using these immunohistochemical methods and standard histochemical techniques, we will identify losses in the number and/or density of synaptic terminals and neuronal cell bodies. To determine the extent of neural loss necessary and sufficient to produce dementia, we will quantify deficits in AD patients compared to controls using an image analysis system. Starting in year 2, we will collaborate with other MADRC laboratories to expand the data set by quantifying pharmacologic and biochemical losses in AD. We will statistically analyze the accumulated data with a multivariate approach to characterize the cumulative neural losses in multiple loci that result in the dementia of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-10
Application #
3768048
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 966 publications